FDA NDC Directory · JSON-LD · Markdown

Clobazam

NDC 69238-1535 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerAmneal Pharmaceuticals NY LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA210039
Dosage form / routeSUSPENSION · ORAL
Active ingredientsCLOBAZAM (2.5 mg/mL)
Marketing started20181022
Package count1

External sources

Source: openFDA. Public-domain (CC0).